The Netherlands: Difference between revisions
| Line 15: | Line 15: | ||
*Prevalence: 5 year, 10 year, and 20 year prevalence by type of cancer, gender, age, region, and year. | *Prevalence: 5 year, 10 year, and 20 year prevalence by type of cancer, gender, age, region, and year. | ||
*Mortality: Count, crude rate, European Standardized Rate (ESR), World Standardized Rate (WSR), Revised European Standardized Rate (RESR) by type of cancer, gender, age, and year. | *Mortality: Count, crude rate, European Standardized Rate (ESR), World Standardized Rate (WSR), Revised European Standardized Rate (RESR) by type of cancer, gender, age, and year. | ||
*Survival | *Survival: Count by type of cancer, Period from diagnosis (1 year and 10 years), age at time of diagnosis, stage at time of diagnosis (TNM), gender, | ||
Revision as of 19:55, 4 April 2023
Cancer Centers
Healthcare System
Administrative or Claims Data
Registries
Database: Netherlands Cancer Registry (NKR)
Primary purpose:
Sponsor, manager or home institution: Comprehensive Cancer Center of the Netherlands (IKNL).
Available type of information:
- Incidence: Count, crude rate, European Standardized Rate (ESR), World Standardized Rate (WSR), Revised European Standardized Rate (RESR) by type of cancer, gender, age, region, and year.
- Prevalence: 5 year, 10 year, and 20 year prevalence by type of cancer, gender, age, region, and year.
- Mortality: Count, crude rate, European Standardized Rate (ESR), World Standardized Rate (WSR), Revised European Standardized Rate (RESR) by type of cancer, gender, age, and year.
- Survival: Count by type of cancer, Period from diagnosis (1 year and 10 years), age at time of diagnosis, stage at time of diagnosis (TNM), gender,
Source of information: Hospitals' reports.
Data level: Regional level (open access) and Patient level (restricted access).
Number of Records: Contains information about all new cases of malignant neoplasms and some benign neoplasms (tumors of the central nervous system, borderline tumors of the ovary, and AL amyloidosis) in Netherlands.
Date range: Varies according to the diagnosis.
Cancer Areas of Interest:
Data access: Regional level data is available here. Access to patient level data can be requested by following the steps described here.
Information/contact for data request: Contact information.
